Equillium (EQ) Accumulated Expenses (2017 - 2026)
Equillium (EQ) reported Accumulated Expenses of $1.6 million for Q1 2026, down 42.49% year-over-year from $2.8 million in Q1 2025, and down 11.4% quarter-over-quarter from $1.8 million in Q4 2025.
Equillium (EQ) Accumulated Expenses (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Accumulated Expenses data on file, last reported at $1.6 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $1.6 million, down 42.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 42.49% YoY), and the FY2025 annual result was $1.8 million, up 315.56% from the prior year.
- Accumulated Expenses eased to $1.6 million in Q1 2026 per EQ's latest filing, from $1.8 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $7.5 million in Q2 2023 and troughed at $437000.0 in Q4 2024.
- A 5-year average of $3.2 million and a median of $2.5 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses surged 7823.94% in 2022, then plunged 93.47% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $3.0 million in 2022, then surged by 125.11% to $6.7 million in 2023, then sank by 93.47% to $437000.0 in 2024, then jumped by 315.56% to $1.8 million in 2025, then dropped by 11.4% to $1.6 million in 2026.
- Business Quant data shows EQ's Accumulated Expenses at $1.6 million in Q1 2026, $1.8 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 437,000.00 |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Dec 31, 2023 | 6.70 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 7.54 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 2.98 Mn |
| Sep 30, 2022 | 2.49 Mn |
| Jun 30, 2022 | 5.38 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 2.51 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 1.78 Mn |